N1,N1,N2,N2-TETRAKIS(PYRIDIN-2-YLMETHYL)ETHANE-1,2-DIAMINE, 95%, 5g

(3-Bromo-6-methoxypyridin-2-yl)methanol, 95.0%, 25g

2,2'-Dipyridyl, min. 95%, for biochemistry, 5 g, glass packaging

Dispensers ROTILABO® II, 1-10 ml, 1 piece

2-methyl-5-(2-methyl-2H-tetrazol-5-yl)aniline, 95.0%, 1g

1-(6-(Dimethylamino)pyridin-3-yl)-2,2,2-trifluoroethan-1-one, 95+%, 10g

Benzo[b]thiophen-2-yl(5-bromo-2-fluorophenyl)methanol, 95.0%, 1g

(2R)-2-Hydroxy-3-methylbutanoic acid, 96.00%, 1g

(2-Bromo-6-fluoro-4-methylphenyl)methanol, 97%, 10g

1-((2R)PYRROLIDIN-2-YL)-4-METHOXYBENZENE, 95.0%, 250mg

4,4'-(1,2,4,5-Tetrazine-3,6-diyl)dibenzoic acid, 97%, 250mg

GC capillary column ROTI®Cap-5 MS Ultra, 60 m, 0.32 mm, 1.00 µm, 1 Piece(s)

5-Bromo-3-fluoro-2-(trifluoromethoxy)pyridine, 97.0%, 250mg